Arkadiy V. Krasnoshtanov

Arkadiy V. Krasnoshtanov

Auto-generated profile, based on publicly available information

Arkadiy V. Krasnoshtanov

JSC Scientific Center for Anti-Infectious Drugs, Almaty, Kazakhstan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2023 in Data in Brief
Verified
Journal Article
Open access
BTBukeyeva Tamara
Bukeyeva Tamara
SMSabina G. Murzageldinova
Sabina G. Murzageldinova
ASAray A. Serikbay
Aray A. Serikbay
AKArkadiy V. Krasnoshtanov
Arkadiy V. Krasnoshtanov
IKIlya S. Korotetskiy
Ilya S. Korotetskiy
The aim of this study was to evaluate phagocytic and oxidative activities of monocytes and granulocytes during combined therapy of mice infected by drug-resistant Staphylococcus aureus SCAID OTT1-2022. The treatment of the infected mice was conducted by using an iodine-containing coordination compound CC-195, antibiotic cefazolin and by a combined therapy with CC-195 and cefazolin. The PHAGOTEST and BURSTTEST kits (BD Biosciences, USA) were used to determine the phagocytic and oxidative activities. The samples were analyzed on a FACSCalibur flow cytometer (BD Biosciences, United States). It was found that the different treatment regiments applied on the infected animals caused a statistically significant differentiation in numbers and activity of monocytes and granulocytes in comparison to the negative and positive control animals (intact and infected but untreated mice, respectively).